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Abstract
Cell transplantation has been suggested as an alternative therapy for temporal lobe epilepsy (TLE) because this can
suppress spontaneous recurrent seizures in animal models. To evaluate the therapeutic potential of human neural stem/
progenitor cells (huNSPCs) for treating TLE, we transplanted huNSPCs, derived from an aborted fetal telencephalon at 13
weeks of gestation and expanded in culture as neurospheres over a long time period, into the epileptic hippocampus of
fully kindled and pilocarpine-treated adult rats exhibiting TLE. In vitro, huNSPCs not only produced all three central nervous
system neural cell types, but also differentiated into ganglionic eminences-derived c-aminobutyric acid (GABA)-ergic
interneurons and released GABA in response to the depolarization induced by a high K+ medium. NSPC grafting reduced
behavioral seizure duration, afterdischarge duration on electroencephalograms, and seizure stage in the kindling model, as
well as the frequency and the duration of spontaneous recurrent motor seizures in pilocarpine-induced animals. However,
NSPC grafting neither improved spatial learning or memory function in pilocarpine-treated animals. Following
transplantation, grafted cells showed extensive migration around the injection site, robust engraftment, and long-term
survival, along with differentiation into b-tubulin III+ neurons (,34%), APC-CC1+ oligodendrocytes (,28%), and GFAP+
astrocytes (,8%). Furthermore, among donor-derived cells, ,24% produced GABA. Additionally, to explain the effect of
seizure suppression after NSPC grafting, we examined the anticonvulsant glial cell-derived neurotrophic factor (GDNF) levels
in host hippocampal astrocytes and mossy fiber sprouting into the supragranular layer of the dentate gyrus in the epileptic
brain. Grafted cells restored the expression of GDNF in host astrocytes but did not reverse the mossy fiber sprouting,
eliminating the latter as potential mechanism. These results suggest that human fetal brain-derived NSPCs possess some
therapeutic effect for TLE treatments although further studies to both increase the yield of NSPC grafts-derived functionally
integrated GABAergic neurons and improve cognitive deficits are still needed.
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Introduction
Epilepsy is a chronic neurological disorder affecting tens of
millions of people worldwide, and more than 30% of patients with
epilepsy still have uncontrolled seizures despite conventional
antiepileptic drugs (AEDs) [1]. Temporal lobe epilepsy (TLE) is
the most frequent and pharmaco-resistant type of adult focal
epilepsy that presents with complex partial seizures, originating
mainly from the mesial temporal structures such as the hippo-
campus or amygdala [2,3]. Loss of c-aminobutyric acid (GABA)-
ergic inhibition and aberrant synaptic reorganization changes
have been observed in the hippocampus of patients with TLE and
animal models [4–6], resulting in an increase in the overall
neuronal excitatory tone compared with inhibitory function [2,7].
Although surgical removal of epileptic foci is a recommended
treatment for patients with TLE, this therapeutic option can lead
to undesirable complications, such as significant cognitive impair-
ment and lasting dependence on AEDs [8]. For this reason, a
continuing need exists for novel approaches that effectively control
seizures in chronic TLE.
Stem cell-based cell transplantation has been investigated
intensively for epilepsy treatment in various animal studies,
although none of these approaches has yet been tested clinically
in patients with epilepsy [9–11]. Over the past few years,
embryonic stem cell (ES)-, neural stem cell (NSC)-, or neural
precursor-based approaches have been examined in animal
models of epilepsy: mouse ES-derived neural precursors in
pilocarpine- or kainic acid-induced status epilepticus (SE) or
kindling-based TLE models [12–15], rat fetal ganglionic eminence
(GE)-derived neural precursors or NSC in the kainic acid-induced
TLE model [16,17], mouse fetal neural precursors from the medial
ganglionic eminence (MGE) in congenital general epilepsy or
pilocarpine-induced adult TLE models [18,19], and immortalized
human fetal brain-derived NSC in the pilocarpine-induced SE
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model [20]. These studies have demonstrated that neural stem/
progenitor cell (NSPC)-based therapies in acute and chronic
models of epilepsy exert anticonvulsant and antiepileptogenic
effects, and may replace degenerated or ablated neurons and
repair damaged neural circuitry [7,9–11].
Prior to the clinical application of NSPCs for epilepsy
treatment, many challenges still must be addressed. First, it is
essential to study human NSPCs (huNSPCs) derived from various
cell sources, such as developing and adult brain tissues, ES, and
induced pluripotent stem cells (iPSCs), for their abilities in terms of
engraftment, migration, differentiation into specific neuronal or
glial cells, seizure control, and functional recovery following
transplantation into the brains of TLE models [21].
A previous study demonstrated that substantial reductions in
spontaneous recurrent motor seizures (SRMSs) were observed for
a short-term period after immortalized human fetal NSPCs were
infused into the tail vein of the animals a day following
pilocarpine-induced SE [20]. However, that study was not
pertinent for treating patients with TLE.
Because patients with epilepsy refractory to AED treatment are
much in need of novel seizure-suppressing therapy, it is significant
to examine the effects of huNSPCs transplantation in animals with
established epilepsy at the time of grafting. Previously, we
cultivated and expanded several types of huNSPCs that were
isolated from different brain regions of an aborted fetus at 13
weeks of gestation as neurospheres in culture dishes [22]. Among
them, telencephalon-derived NSPCs gave rise to not only neuronal
and glial cells, but also differentiated into more neurons and
GABA+ cells than other brain region-derived NSPCs in vitro.
The kindling model is one of the most commonly used animal
models of TLE. The advantages of kindling are that specific
regions of the brain can be stimulated in a controlled fashion
[5,23]. However, in the kindling model, seizures are evoked and
SRMSs are scarce. The pilocarpine-induced model of TLE is
characterized by robust and frequent SRMSs, behavioral abnor-
malities, and poor responses to AEDs [2,5,24]. These animal
models develop several typical lesions that appear to be analogous
to those in human TLE.
Given this background, we investigated whether epileptic
phenotypes could be improved in both kindling and pilocarpine-
induced TLE models by human fetal brain-derived NSPC grafts
into the hippocampus after epileptic seizures emerged, and
characterized the distribution, engraftment, and the differentiation
patterns of cells implanted in adult recipients. Grafted cells showed
extensive migration, robust engraftment, long-term survival,
differentiation into three central nervous system (CNS) neural cell
types, and provided a large number of GABAergic interneurons
around the implanted sites. Moreover cell grafting has therapeutic
potentials for treating TLE, particularly with regard to seizure
suppression. However, further studies to both increase the yield of
NSPC grafts-derived functionally integrated GABAergic neurons
and improve cognitive deficits are still needed.
Materials and Methods
Cell culture
Human fetal brain tissue from a cadaver at 13 weeks of
gestation was obtained with full parental written consent and
approval of the Research Ethics Committee of Yonsei University
College of Medicine, Seoul, Korea (Permit Number: 4-2003-0078)
[25]. In this study, huNSPCs for transplantation were derived
from such a single donated fetal tissue. The culture of NSPCs was
previously described in detail [22]. Briefly, after dissociation of
telencephalic tissue in trypsin (0.1% for 30 min; Sigma, St. Louis,
MO), cells were plated at 46105 cells/mL in serum-free culture
medium (DMEM/F12; Gibco, Grand Island, NY), N2 formula-
tion (1% v/v; Gibco), and 8 mg/mL heparin (Sigma) supplement-
ed with 20 ng/mL fibroblast growth factor-2 (FGF-2; R&D
Systems, Minneapolis, MN) and 10 ng/mL leukemia inhibitory
factor (LIF; Sigma). All cultures were maintained in a humidified
incubator at 37uC and 5% CO2 in air, and half of the growth
medium was changed every 3–4 days. Proliferating single cells in
culture generated free-floating neurospheres during the first 2–5
days of growth. They were passaged every 7–8 days by dissociation
of bulk neurospheres with 0.05% trypsin/EDTA (T/E; Gibco).
For proliferation conditions, 86105 cells/well were maintained
with mitogens in 6-well plates for quantitative RT-PCR, Western
blot and HPLC analysis. For differentiation conditions, neuro-
spheres were trypsinized and dissociated into single cells, and cells
were then placed on poly-L-lysine (PLL; 10 mg/mL; Sigma)-
coated 8-well chamber slides (Nunc, Roskilde, Denmark) at 86104
cells/well for immunocytochemical analysis or on PLL-coated 6-
well plates (Sigma) at 16106 cells/well for quantitative RT-PCR,
Western blot and HPLC analysis in the growth medium without
mitogens. The medium was replaced every 2 days, and cells were
analyzed at day 7 of differentiation.
Quantitative real-time reverse transcription-polymerase
chain reaction (qRT-PCR)
Total RNA was isolated from cell cultures using the TRI
reagent (MRC, Inc., Cincinnati, OH), and 2 mg of RNA was
reverse-transcribed into cDNA using random hexamer primers
(Bioneer, Daejeon, Korea) and Superscript reverse transcriptase
(Invitrogen, Grand Island, NY) in a thermal cycler (Eppendorf,
Happauge, NY) according to the manufacturer’s instructions.
Quantitative RT-PCR was carried out in a total volume of 10 mL
containing 5 mL of LightCyclerH 480 SYBR Green I Master
(Roche Diagnostics Ltd., Rotkreuz, Switzerland), 0.5 mM of each
primer and 2.5 mL of 1:10 diluted cDNA using LightCyclerH 480
instrument (Roche Diagnostics Ltd). The cycling conditions were:
95uC for 5 min, followed by 45 cycles of 95uC for 10 s, 60uC for
10 s, and 72uC for 10 s. All the samples were carried out in
triplicates. The expression levels of each mRNA expression were
normalized to the housekeeping gene GAPDH using LightCyclerH
480 Software, Version 1.5 (Roche Diagnostics Ltd). Primer
sequences for FOXG1, DLX2, NKX2.1, GAD1, calbindin2
(CALB2) and somatostatin (SST) have been previously described
[26]. Other primer sequences were retrieved from PrimerBank
Database http://pga.mgh.harvard.edu/primerbank/ [27], with
the exception of SLC32A1 which was designed using ProbeFinder
software Version 2.49 from Roche Applied Science. Sequences of
primer sets were listed in Table S1.
Western blots
At the protein level, the expression of GAD65 (GAD2) and
GAD67 (GAD1) was quantified by Western blotting. Cells were
lysed in tissue protein extraction reagent (T-PER reagent; Pierce,
Rockford, IL) with a protease inhibitor cocktail (Sigma), and
lysates were centrifuged (16,0006g, 30 min, 4uC). The superna-
tant was collected and stored at –80uC. The samples were assayed
for total protein using a bicinchoninic acid assay (BCA kit; Pierce),
and 20 mg of protein was mixed with 2% b-mercaptoethanol in
tricine sample buffer (Bio-Rad, Hercules, CA) and denatured by
heating to 95uC. Then, samples (20 mL) were loaded onto 10%
Tris–glycine gels, and the proteins were transferred from the gel
onto a 0.45-mm nitrocellulose membrane (Thermo Scientific,
Suwanee, GA) over 4 h at 4uC. The protein blots were blocked
with 5% skimmed milk in TBST and then incubated with 0.25%
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bovine serum albumin in TBST overnight at 4uC with the
following primary antibodies: anti-GAD65 (1:1,000; Sigma), anti-
GAD67 (1:1,000; Chemicon, Temecula, CA), or b-actin (1:2,000;
Sigma). Immunoblots were rinsed with TBST, incubated with a
horseradish peroxidase-conjugated secondary antibody (1:20,000;
Jackson Immunoresearch, West Grove, PA) for 1 h at room
temperature, and developed using SuperSignal West Pico Chemi-
luminescent substrate (1:20,000; Thermo Scientific). The images
were scanned with a Fujifilm LAS-4000 mini imager and analyzed
with the MultiGauge software (Fujifilm, Tokyo, Japan).
High-performance liquid chromatography (HPLC)
Intracellular GABA content was measured 7 days after plating
as follows. The cells under proliferation or differentiation
conditions were washed twice with ice-cold Hank’s balanced salt
solution-HEPES (H-H) buffer (Gibco), treated with 0.4 M
perchloric acid, and scraped from each well. The cell lysates were
centrifuged (16,0006g, 4uC, 30 min), and the supernatant was
collected and adjusted to pH 7–8. The samples were filtered and
stored at 280uC. To measure the level of GABA release, the cells
were incubated in basal medium (144 mM NaCl, 1 mM MgCl2,
4 mM KCl, 1.8 mM CaCl2, 5 mM glucose, and 10 mM HEPES)
and high K+ medium (same as basal medium except 94 mM NaCl
and 53 mM KCl) for 60 min. After incubation, the supernatant
was collected, filtered, and stored at 280uC. The GABA levels in
the cell lysates and supernatants from basal and high K+ media
were analyzed by reverse-phase HPLC using o-phthalaldehyde
derivatization with a fluorescence detector [28,29]. All experi-
ments were done in triplicate. Values were normalized to total
cellular protein, measured using the BCA assay.
Immunostaining
For immunocytochemical analysis, cultured cells were fixed
with 4% paraformaldehyde (PF) in PIPES buffer (Sigma), rinsed
with phosphate-buffered saline (PBS) solution, blocked with 3%
bovine serum albumin (Sigma), 10% normal horse serum, and
0.3% Triton X-100 (Sigma) in PBS. For immunohistochemical
analysis, animals were deeply anesthetized with ketamine (75 mg/
kg, i.p.) and xylazine (30 mg/kg, i.p.) and perfused with 4% PF in
0.1 M PIPES buffer. Brains were then removed, post-fixed,
transferred in 30% sucrose in PBS for cryoprotection, and frozen
in O.C.T compound (Sakura Finetek, Torrance, CA, USA). The
brains were coronally sliced into 16-mm sections using a cryostat.
Sections were washed in PBS and blocked as mentioned above.
Cultures or Sections were incubated with following primary
antibodies: anti-human specific nestin (anti-hNestin; 1:200;
Chemicon), anti-human specific nuclear pore (hNP; 1:20; Onco-
gene, Cambridge, MA), anti-human specific cytoplasm SC121
(1:500; Stem Cells, Inc., Cambridge, UK), anti-human specific
GFAP SC123 (1:500; Stem Cells, Inc., Cambridge, UK), anti-glial
fibrillary acidic protein (GFAP; 1:1,000; Dako, Glostrup, Den-
mark), anti-neuronal class b-tubulin III (TUJ1; 1:1,000, Covance,
Princeton, NJ), anti-GABA (1:500; Sigma), anti-calretinin (1:2,000;
Chemicon), anti-GAD65 (1:250; Sigma), anti-GAD67 (1:500;
Chemicon), anti-platelet-derived growth factor receptor alpha
(PDGFR-a; 1:100; Santa Cruz Biotechnology, Santa Cruz, CA),
anti-adenomatous polyposis coli-CC1 (APC-CC1; 1:30; Abcam,
Cambridge, MA), anti-Olig2 (1:500; Millipore, Billerica, MA),
anti-glial cell-derived neurotrophic factor (GDNF; 1:50; Santa
Cruz Biotechnology), anti-S100b (1:1000; Sigma), and anti-human
specific nuclei (hNuc; 1:100; Chemicon) antibodies. Species-
specific secondary antibodies, conjugated with fluorescein (FITC;
1:180; Vector, Burlingame, CA) or Texas Red (TR; 1:180; Vector)
were used to detect the binding of primary antibodies. Specimens
were mounted using Vectashield mounting medium with 4,6-
diamino-2-phenylindole (DAPI; Vector), and were analyzed by an
immunofluorescence microscopy (BX51; Olympus, Center Valley,
PA) or a confocal laser scanning microscopy (LSM 700; Carl Zeiss,
Oberkochen, Germany).
Quantification
For in vitro quantification, the total number of TUJ1-, PDGFR-
a-, GFAP-, GABA-, CALB2-, and GAD2-expressing cells were
counted in three to five randomly selected fields. The percentage
of each marker-positive cell among total DAPI-positive cells was
calculated. This sampling was replicated three times.
To quantify the survival and migration of engrafted huNSPCs,
the number of BrdU+ cells were quantified in every fifth section
through the entire anteroposterior extent of grafts at 4 and 8 weeks
after grafting in the kindling model. Estimates of total BrdU+ cell
numbers from raw cell counts were corrected according to the
Abercrombie formula [30]. The mean yield of surviving cells in
each rat was depicted as the percentage of transplanted cells. Cell
numbers versus distance to the injection site were quantified and
values were expressed as a percentage of the total number of
surviving cells. To determine differentiation patterns of grafted
cells, sets of 50–100 BrdU+ or hNuc+ cells from every fifth section
were used to calculate the percentages of TUJ1+, GFAP+, APC-
CC1+, PDGFR+, or GABA+ cells at 8 weeks following transplan-
tation.
Kindling process
Adult male Sprague–Dawley rats (,300 g) were kept on a 12/
12-h light/dark cycle (lights on at 07:00 h) with free access to food
and water. This study was performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institute of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of Yonsei University College of Medicine (Permit
Number: 2010-0201). The rats were anesthetized with ketamine
(75 mg/kg, i.p.) and xylazine (30 mg/kg, i.p.) and implanted with
a bipolar electrode-cannula guide (Plastics One, Roanoke, VA)
into the right hippocampal CA3 using the following stereotaxic
coordinates: 4.2 mm lateral, 4.52 mm caudal, and 4.5 mm ventral
to bregma. The electrode-cannula consisted of a cylindrical plastic
pedestal molded around a piece of stainless steel tubing, which
guided an infusion cannula, and two individually insulated wire
electrodes that attached to the sides of the stainless steel tubing
[31]. Via the stainless steel tubing, the infusion cannula penetrated
to a consistent depth and was used to transfer vehicle or
dissociated NSPCs. Two steel screws served as ground electrodes.
All electrodes were anchored in place with dental cement. After a
recovery period of 1 week, afterdischarge threshold (ADT) was
determined by passing constant pulse trains (1 ms, biphasic
rectangular wave, 50 Hz for 1 s). The initial current of 10 mA
was delivered, increasing the current intensity in steps of 10 mA (to
a maximum of 150 mA), with intervals of 1 min between current
deliveries until an afterdischarge (AD) was seen, defined as
poststimulus electroencephalogram (EEG) spikes with a frequency
of greater than 1 Hz and an amplitude at least two times greater
that of the pre-stimulus recording [32]. The rats were stimulated at
the ADT intensity twice daily until five consecutive stage 5 or
higher seizures (according to the additional Racine scale [33])
were elicited: Stage 1, facial movements only; Stage 2, facial
movements and head nodding; Stage 3, facial movements, head
nodding, and forelimb clonus; Stage 4, facial movements, head
nodding, forelimb clonus, and rearing; Stage 5, facial movements,
head nodding, forelimb clonus, rearing, and falling; Stage 6,
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cluster of multiple Stage 5 seizures; Stage 7, jumping and running
seizures; and Stage 8, Stage 7 plus tonic hindlimb extension and
tail rigidity, sometimes culminating in death. In total, 25 fully
hippocampal-kindled rats were randomly allocated to the two
groups: the vehicle-injected control group (n= 13) or the NSPC-
transplanted group (n= 12). The average ADT between the
groups was not significantly different (47.7611.4 and
44.167.0 mA in the vehicle and NSPCs groups, respectively;
P= 0.80).
For fully hippocampal-kindled animals, electrical responses
generally consisted of three epochs: primary AD, silent period, and
subsequent secondary AD [34]. AD duration (ADD) refers to the
cumulative duration of primary and secondary ADs recorded
within ,2–3 min after stimulation at the intensity of ADT. In
addition to ADD, behavior seizure stage and seizure duration were
measured. Seizure stage was classified according to the additional
Racine scale. Seizure duration was defined as the period of limbic
seizure (stages 1–2) and subsequent motor seizure (stages 3–7),
excluding limbic seizure after motor seizure [35].
Induction of status epilepticus by pilocarpine
Adult male Sprague–Dawley rats (200–220 g) were infused with
lithium chloride (127 mg/kg, i.p.; Sigma) 24 h prior to the
administration of pilocarpine. On the next day, the rats were
injected with methylscopolamine bromide (1 mg/kg, i.p.; Sigma)
to limit the peripheral effects of pilocarpine, and 30 min later were
injected with pilocarpine hydrochloride (45 mg/kg, i.p.; Sigma) to
induce SE. Seizure events in pilocarpine-treated rats were scored
according to the additional Racine scale [33], and rats that did not
develop stage 5 or higher seizure were excluded from this study.
Diazepam (Samjin, 10 mg/kg, i.p.) was injected 1 h after SE onset
to cease seizure activity. The rats that went into SE were injected
with 2.5 mL of 5% dextrose intraperitoneally twice a day and were
given a moistened rat diet during the following 2–3 days. For 14–
20 d after SE, pilocarpine-treated rats were monitored to confirm
the emergence of SRMSs by video recording. The frequency of
SRMSs (stages 3–7 seizure) was scored for 12 h/day. After
monitoring, epileptic rats were randomly allocated to two groups:
the vehicle-injected control group (n= 18) or the NSPC-trans-
planted group (n= 21). The frequency of SRMSs before trans-
plantation between two groups was not significantly different
(0.1860.04 and 0.1560.02 seizures/day in the vehicle and NSPCs
groups, respectively; P= 0.87).
Preparation and transplantation of NSPCs
huNSPCs were maintained by passaging through the dissoci-
ation of bulk neurospheres and cryopreserved at each passage in
the Good Manufacturing Practice facility. For transplantation,
NSPCs taken at between passage number 10 (P10) and P20 were
selected and prepared. Cells were labeled with bromodeoxyuridine
(BrdU; 3 mM; Sigma) for 5 days before grafts. At the time of
grafting, cells were harvested by trypsinization after which the
enzymatic activity was halted by soybean trypsin inhibitor (Sigma).
The cells were centrifuged (9006g, 3 min), the cell pellet was
washed three times with H-H buffer, and the entire cell pellet was
then resuspended in H-H buffer at a density of 1.06105 cells/mL.
The concentrated NSPCs in a sterile freezing tube (Nunc) were
then delivered to the animal operation room. For the kindling
model, 1 week after reaching the kindling criteria, rats were
anesthetized and injected with 4 mL of vehicle (H-H buffer only) or
NSPC suspension into the stimulated site (CA3 region of the right
hippocampus) using an infusion cannula and tubing (Plastics One).
For the pilocarpine model, at 3 weeks after SE, epileptic rats were
anesthetized and injected with 4 mL of vehicle or NSPC
suspension into the CA3 regions of bilateral hippocampus using
the following stereotaxic coordinates: 4.2 mm left and right lateral,
4.52 mm caudal, and 5.0 mm ventral to bregma. Vehicle or
NSPC suspension was infused at a flow rate of 1 mL/min using a
10-mL Hamilton syringe placed on an infusion pump (KD
Scientific, Holliston, MA) controlled by a microprocessor. All
animals in both groups received daily injections of cyclosporine
(10 mg/kg, i.p.) from a day before transplantation to the end of the
experiment.
Evaluation of NSPC grafts on kindled seizures and SRMS
For the kindling model, after a recovery period of 1 week
following transplantation, the hippocampus of each animal was
stimulated weekly at ADT intensity. Regular determinations of
seizure parameters—ADD, seizure duration, and seizure stage—in
both vehicle-injected and NSPC-transplanted groups were per-
formed weekly for 8 weeks with video and EEG recordings. For
the pilocarpine model, the behavior of epileptic rats was observed
at 1–3 months following transplantation to analyze the frequency,
severity and duration of SRMSs in both the vehicle-injected and
NSPC-transplanted groups. Starting at 2 weeks following trans-
plantation, the rats were video-monitored for 60 h per week
(12 h/day, 5 days/week, 2 weeks/month, and 360 h in total). Rats
were given free access to water and food in individual cages and
video-monitored during the daylight period. The video recordings
were analyzed by observers blinded to group allocation. Rats were
scored according to the same additional Racine scale used in the
establishment of the kindled model [33]. The frequency and
severity of seizure, and the total time spent in seizure were assessed
in each rat. At the end of experiments, all rats were sacrificed by
CO2 inhalation, in accordance with institutional and AVMA
guidelines for the euthanasia [36].
Morris water maze
The Morris water maze test was performed to assess the effect of
huNSPCs grafts on learning and memory function in epileptic rats.
The detailed method has been previously described [37]. Briefly, a
circular polypropylene pool (200 cm in diameter and 40 cm in
height) was filled with water (2261uC) made opaque with a food
coloring agent, rendering it impossible for rats to see through it.
On the pool rim, four points were designated (north, east, south,
west), dividing the pool into four quadrants (NE, NW, SW, SE). A
circular platform (15 cm in diameter and 30 cm in height) was
positioned at the center of the SE quadrant and hidden 1 cm
below the water surface, and the position of the platform was kept
unchanged throughout the training days. A trial started when the
rat was positioned in the water from a quasirandom start points
and ended when the rat reached and escaped onto the hidden
platform. The swim paths of rats were recorded by a video
tracking system (SMART; Panlab, Barcelona, Spain) and analyzed
thereafter. For the pilocarpine model, the water maze test was
performed 3 months following transplantation in an age-matched
intact group (n= 6), the vehicle-injected group (n= 11), and the
NSPC-transplanted group (n= 12). Rats were trained for 4 days,
and the training day consisted of six trials with an interval of 5–
15 min. If the rat was not able to find the platform in 120 s, the rat
was guided to it by the investigator. Mean escape latency was
calculated for each day during the training days. At the probe trial,
on day 5, the rats were positioned in the opposite quadrant where
the platform was previously located and allowed to swim in the
pool without the platform for 60 s. All parameters of memory
retention were measured. At the end of experiments, all rats were
sacrificed by CO2 inhalation as described above.
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Determination of GDNF-positive astrocytes in the
hippocampus
To investigate whether huNSPC grafting affects the level of
GDNF expression in host hippocampal astrocytes, double
immunofluorescence for GDNF and the astrocytic marker,
S100b was done 12 weeks after transplantation in age-matched
intact controls and pilocarpine-treated rats that received vehicle or
NSPCs. The ratio of double-labeled GDNF- and S100b-positive
cells among total S100b-positive cells in the bilateral CA3 regions
of the hippocampus was determined by a confocal laser scanning
microscopy in every 10th section throughout the dorsal hippo-
campus. At least 80 S100b-positive cells per animal were analyzed
at 400x magnification.
Timm staining
After completion of the Morris water maze, pilocarpine-induced
epileptic rats were anesthetized with ketamine (75 mg/kg, i.p.) and
xylazine (30 mg/kg, i.p.) and perfused transcardially for 10 s with
0.1% sodium sulfide, 3 min with 3% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.4), and 7 min with 0.1% sodium sulfide
[38]. The brains were postfixed for 24 h at 4uC and then
cryoprotected in 30% sucrose in 0.1 M phosphate buffer. The
brains were embedded in O.C.T compound (Sakura Finetek),
coronally sectioned at 16-mm, and stored at 220uC. A 1-in-10
series of sections from dorsal hippocampus was dried, and
developed for 60 min in a solution of 50% gum Arabic
(120 mL), 20 ml of 2 M citrate buffer, 3.4 g of hydroquinone in
60 mL of H2O, and 1 mL of 17% silver nitrate [39]. After rinsing,
sections were dehydrated in graded alcohol and mounted with
Permount (Fisher Scientific, Fair Lawn, NJ). Sections from age-
matched intact control rats were stained at the same time as
sections from pilocarpine-induced epileptic rats. Mossy fiber
sprouting was assessed by scoring a five-point scale, as previously
reported [40]. The Timm score of each section was calculated by
an observer blinded to group allocation, and averaged from all the
stained sections of bilateral hippocampi.
Statistical analysis
All data are shown as means 6 standard error of the mean
(SEM). Differences in GABA content or GABA release from
huNSPCs were evaluated with the Mann–Whitney U-test.
Significant differences in average yield of viable huNSPCs and
between 4 and 8 weeks after transplantation in the kindling model
were analyzed with Student’s t-test. To compare the mean
rostrocaudal distance to injection site of grafted NSPCs between 4
and 8 weeks post-transplantation, we used Student’s t-test. The
Timm scores were analyzed using one-way analysis of variance
(ANOVA) followed by the post hoc Bonferroni test. Comparison of
percentages of S100b+ astrocytes expressing GDNF in the CA3
region of the hippocampus among the three groups was performed
by one-way ANOVA with LSD post hoc test. In the kindling
model, Student’s t-test was used to compare the effects of NSPC
transplantation with vehicle injection on ADD, seizure duration,
and seizure stage. Escape latency in the Morris water maze was
compared among groups using repeated-measures ANOVA with
Tukey’s HSD post hoc procedure. Dwell time in the target
quadrant, dwell time in the platform area, latency to the platform
area, and platform area crossings in the Morris water maze were
compared among groups using one-way ANOVA followed by the
post hoc LSD test. In the pilocarpine model, Student’s t-test was
used to compare the effects of NSPC transplantation with vehicle
injection on the frequency, severity and duration of SRMSs.
Differences were considered statistically significant for P,0.05.
Group sizes were calculated based on power analysis (PASS
program). We used a power of 0.8 and significance levels of 0.05.
Results
Multipotent human NSPCs and differentiation into
GABAergic neurons in culture
huNSPCs have the ability to differentiate into all three neural
cell types in vitro: neurons, oligodendrocytes, and astrocytes
(Fig. 1A–C). At 7 days after plating of neurosphere-derived single
cells under differentiation conditions, ,61% of NSPCs had
differentiated into TUJ1+ neurons, ,2% into PDGFR-a+
oligodendrocyte progenitors, and ,5% into GFAP+ astrocytes
(Fig. 1J). To investigate whether NSPCs could differentiate into
GABAergic interneurons, we examined the expression of GA-
BAergic neuronal markers in NSPCs using Western blots and
immunocytochemistry (Fig. 1D-J). Histological analysis showed
that ,26% of NSPC-derived differentiated cells expressed GABA
(Fig. 1E, J), and ,37% of NSPC-derived TUJ1+ neurons
expressed GABA with small bipolar processes (Fig. 1D–F, J).
Additionally, ,30% of cells expressed interneuron subtype marker
CALB2, also known as calretinin [26] (Fig. 1G, J), and ,11% of
cells expressed GABA-synthesizing enzyme, GAD2 (Fig. 1H, J).
Western blot showed that protein levels of GAD1 and GAD2, the
two isoforms of the GABA-synthesizing enzyme, were elevated
markedly in cells under differentiation (Diff) conditions, versus
proliferation (Prol) conditions (Fig. 1I).
We analyzed transcript expression for region-specific and
GABAergic interneuron lineage markers in huNSPCs using
qRT-PCR (Fig. 2). Telencephalic marker FOXG1 and ventral
telencephalic markers (OLIG2, ASCL1, and DLX2) were
expressed in cells under both Prol and Diff conditions [26,41],
and the expression levels of makers were significantly elevated
under Diff condition compared to under Prol condition except
OLIG2 (Fig. 2A, B). The MGE, marked by NKX2.1 and LHX6
expression, is known the primary source of cortical interneurons
both in rodents and in humans, and the caudal ganglionic
eminence (CGE), marked by NR2F2 (COUP-TFII) expression,
give rise to a greater proportion of cortical interneurons in humans
than in rodents [26,42-45]. We found that NSPCs not only
expressed MGE markers, but also abundantly the CGE marker
(Fig. 2C, D). In addition, GABAergic markers (GAD1, SLC32A1,
and SLC6A1) and interneuron subtype markers (CALB2, SST,
and NPY) were robustly expressed under differentiation conditions
(Fig. 2E, F). These data demonstrate that huNSPCs not only give
rise to all three CNS neural cell types, but also that many of them
differentiate into the MGE and CGE-derived GABAergic
interneurons.
HPLC analysis of GABA release from human NSPCs in
culture
After finding evidence that huNSPCs could differentiate into
GABAergic neurons, we examined whether NSPC-derived cells
actually released GABA under basal and high K+ conditions in
culture using HPLC. Intracellular GABA content of NSPCs under
differentiation conditions (8,018.46514.9 pmol/mg, n= 3) was
about twice higher than that under proliferation conditions
(4,288.46118.4 pmol/mg) (P= 0.010; Fig. 3A). When NSPCs
under differentiation conditions were incubated in basal or high
K+ medium, the intracellular GABA content of cells incubated in
basal medium (11,119.86871.8 pmol/mg, n= 3) was slightly
higher than that in the high K+ medium (8,494.06682.0 pmol/
mg) (P= 0.20; Fig. 3B). However, the amount of GABA released
from differentiated NSPCs into the medium was significantly
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higher in the high K+ medium (507.69611.39 pmol/mg) than
that in the basal medium (293.20623.78 pmol/mg) (P= 0.029;
Fig. 3C), suggesting that huNSPC-derived differentiated cells can
increase efflux of GABA in response to depolarization induced by
elevated K+.
Engraftment and distribution of human NSPCs following
transplantation
In the kindling model, we transplanted NSPCs into the CA3
region of the right hippocampus of fully kindled rats. To evaluate
the grafted cells, animals were killed at 4 and 8 weeks following
transplantation, and brain tissues were processed for immunohis-
tochemistry. BrdU+ grafted cells had migrated away from the
injection site and dispersed throughout the hippocampus. Many
grafted cells were predominantly located in the radiatum layer of
the CA3 region, molecular and granular layer of the dentate gyrus
(DG), and hilus of the hippocampus (Fig. 4A-F).
Quantification of the total number of BrdU+ cells demonstrated
that the survival rate of grafted cells was 57.4616.6%
(229,469.1666,242.0, n= 4 rats) and 29.3610.0% (117,127.86
39,809.3, n= 4) at 4 and 8 weeks following transplantation,
respectively. To evaluate the migratory ability of NSPCs, we
quantified the number of grafted cells versus rostrocaudal
distances to injection site at 4 and 8 weeks after transplantation
Figure 1. Multipotent human NSPCs and differentiation into GABAergic neurons in culture. (A–C) Under differentiation conditions,
differentiation of fractions of NSPCs into TUJ1+ neurons visualized by Texas Red (A), PDGFR-a+ oligodendrocyte progenitors identified by fluorescein
(B), and GFAP+ astrocytes imaged using fluorescein (C) could be observed. Nuclei were counterstained with DAPI. (D–F) Many NSPC-derived
differentiated neurons were co-labeled with TUJ1 (red) and GABA (green) with small bipolar processes. (G, H) Fractions of NSPC-derived cells also
expressed CALB2 (calbindin2, green) and GAD2 (GAD65, green). Scale bar, 50 mm. (I) Western blot analysis shows that GAD1 and GAD2 were
expressed highly in NSPCs under differentiation conditions. (J) The bar chart illustrates percentages of NSPCs that exhibit differentiation into TUJ1+
neurons, PDGFR-a+ oligodendrocyte progenitors, GFAP+ astrocytes, GABA+ neurons, CALB2+ neurons, and GAD2+ neurons. Quantification of the data
presented in (J); mean 6 SEM (n= 3).
doi:10.1371/journal.pone.0104092.g001
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Figure 2. Transcript expression profiling of human NSPCs. (A–F) Expression patterns of genes associated with development and function of
GABAergic neurons were analyzed in NSPCs under proliferation (Prol) and differentiation conditions (Diff) using quantitative RT-PCR. The expression
levels of each mRNA expression were normalized to levels of GAPDH. Panels show: telencephalic (A), ventral telencephalic GABAergic neuronal
lineage (B), medial ganglionic eminence (MGE) (C), caudal ganglionic eminence (CGE) (D), GABAergic neuron (E), and interneuron (IN) subtype
markers (F). The expression levels of makers were significantly elevated under Diff condition compared to under Prol condition except OLIG2. Data
represented as mean 6 SEM (n= 3).
doi:10.1371/journal.pone.0104092.g002
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(n= 4, respectively). Grafted cells showed to migrate from the
injection site in both rostral and caudal directions. There was a
significant difference between the mean distance of migration at 8
weeks and that at 4 weeks (1.4460.18 vs. 0.9660.07 mm,
P= 0.041), suggesting that rostrocaudal migration is continuously
progressing until 8 weeks post-transplantation. In contrast, when
NSPCs were transplanted into the CA3 region of the right
hippocampus of age-matched non-kindled rats, there was no
apparent grafted cell migration from CA3 to the DG (Fig. S1).
These results suggest that transplanted huNSPCs engraft robustly,
migrate extensively, and survive for a long time after grafting into
epileptic hippocampus. In the pilocarpine model, grafted cells also
showed robust engraftment and long-term survival, and extensive
distribution around the injection site when brains were analyzed
12 weeks following transplantation (Fig. S2).
Differentiation of human NSPCs in epileptic rats
following transplantation
To study differentiation patterns of donor-derived cells, the
whole hippocampal area of kindled rats was analyzed at 8 weeks
following transplantation. BrdU+ cells were co-labeled with the
early neuronal marker TUJ1 in the CA3 region of the
hippocampus (Fig. 5A–C) and fimbria (Fig. 5D–F). Confocal
microscopic images of hNP+-grafted cells demonstrated dual
labeling with the TUJ1 antibody (Fig. 5G–J). Quantification
revealed that donor-derived cells differentiated into TUJ1+
neurons (33.864.0%, n= 4), APC-CC1-expressing oligodendro-
cytes (27.766.2%, n= 4), and GFAP-expressing astrocytes
(8.261.8%, n= 4) in the hippocampus (Fig. 5K, M). About 40%
of GFAP-expressing astrocytes expressed GDNF (Fig. S3).
Additionally, ,24% of BrdU+ cells expressed GABA in the
hippocampus and surrounding structures (n= 4; Fig. 6A–I).
Confocal microscopy images showed that BrdU+ cells co-localized
with GABA+ cells (Fig. 6J), and hNP+ cells dual-labeled with
GABA had small bipolar neuronal processes (Fig. 6K–N). Most
grafted cells, however, appeared not to show the morphological
features of mature interneurons resembling host inhibitiory
hippocampal interneurons. A few BrdU+ cells (,3%) were found
to express CALB2, a GABAergic interneuron subtype (Fig. 6O–
Q). In the pilocarpine model, grafted NSPCs also differentiated
into TUJ1+ neurons, OLIG2+ oligodendrocyte progenitors, and
GFAP+ astrocytes, although a large number of cells expressed an
undifferentiated cell marker, nestin (n= 4). Moreover, ,21% of
donor-derived cells expressed GABA and few of them expressed
GDNF (Fig. S4). Most grafted cells also appeared not to show the
morphological features of mature interneurons. These findings
suggest that huNSPCs can give rise to neurons including
GABAeric neurons albeit still immature, oligodendrocytes, and
astrocytes in the epileptic hippocampus and adjacent structures in
TLE models.
Effect of human NSPC transplantation on kindled
seizures and SRMS
The effect of huNSPCs transplantation on kindled seizure
activity was evaluated weekly for 8 weeks following transplanta-
tion. Compared with the vehicle-injected group (n= 13), the
transplanted group (n= 12) showed substantial decreases in three
seizure parameters—ADD on EEG examination, behavioral
seizure duration, and seizure stage—although no significant
difference was observed in seizure parameters between pre-grafts
in both groups (Fig. 7A–C). In the transplanted group, ADD
decreased steadily until 4 weeks after grafting and significantly
decreased compared with the vehicle group at the third week (24%
reduction, P= 0.047) and fourth week (39% reductions, P= 0.005)
(Fig. 7A).
Seizure duration declined significantly during the first, second,
and third weeks after grafting (27%, 22%, and 25% reductions,
respectively; P,0.05; Fig. 7B). Seizure stage also displayed a
significant decrease from the second to sixth week (P,0.05;
Fig. 7C). Furthermore, seizure parameters in NSPC-transplanted
rats did not exceed those of vehicle-injected rats at almost every
time point. Thus, huNSPCs grafting resulted in significant
reductions in all seizure parameters in the kindling model.
However, the significant anticonvulsant effect was not permanent,
but disappeared slowly by the seventh week following transplan-
tation (Fig. 7).
To examine the effect of huNSPCs transplantation on
spontaneous seizures, we performed video monitoring in the
pilocarpine model. Rats were video-monitored to document the
emergence of SRMSs for 14–20 d after pilocarpine-induced SE.
Previously, adult rats that underwent pilocarpine-induced SE for
1 h were reported to exhibit spontaneous seizures before 20 days
after SE [24]. We also observed the emergence of at least one
spontaneous seizure in all experimental animals. After confirma-
tion of the occurrence of SRMSs, we injected NSPCs into both
right and left hippocampus at 3 weeks after SE, and the rats were
then video-monitored from 2 weeks to 3 months following
transplantation. During the video monitoring period, we measured
Figure 3. HPLC analysis for GABA in human NSPCs. (A) huNSPCs contain GABA under both proliferation (Prol) and differentiation (Diff)
conditions in culture. Note that the total intracellular GABA content of NSPCs was significantly higher under Diff conditions than under Prol
conditions. (B, C) NSPCs under Diff conditions were incubated in basal (4 mM KCl) or high K+ (53 mM KCl) medium, and intracellular GABA content (B)
and GABA release into the medium (C) were quantified. * Significantly different from that under Prol conditions at P,0.05; { significantly different
from that in the basal medium at P,0.05; error bars indicate 6SEM.
doi:10.1371/journal.pone.0104092.g003
Human Neural Stem/Progenitor Cell Grafts for Temporal Lobe Epilepsy
PLOS ONE | www.plosone.org 8 August 2014 | Volume 9 | Issue 8 | e104092
Figure 4. Engraftment and distribution of human NSPCs into the hippocampus of kindled rats. (A–E) Serial sections (320 mm apart)
throughout the hippocampus were used to determine the location of BrdU+ grafted cells, visualized with fluorescein at 4 weeks following
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the frequency and severity of SRMS, and the total time spent in
SRMS (Fig. 8). The mean frequencies of SRMSs in transplanted
group (0.1060.03 and 0.1260.06 seizures/day at 2 and 3 months
after grafting, respectively; n= 21) were significantly reduced
compared with those in the vehicle group (0.2660.06 and
0.6160.15, respectively; n= 18; Fig. 8A). Thus, epileptic rats that
received NSPC grafts into the hippocampus had significantly
lower seizure frequencies as compared to vehicle-injected epileptic
rats at 2 months (62% reduction, P= 0.029) and 3 months (80%
reduction, P= 0.004) following transplantation. Seizure severity
transplantation. A–E panels are representative images of serial coronal sections of the hippocampus which are ordered from anterior to posterior.
Grafted cells had migrated apart from the injection site (arrowhead in C) and dispersed throughout the adjacent hippocampal subfields. Many grafted
cells were predominantly placed in the radiatum layer (Rad) of the CA3 region, molecular (ML) and granular cell layer (GCL) of the dentate gyrus (DG),
and hilus (HI) of the hippocampus. Dotted lines denote the boundary between HI and GCL of the DG. In panel C, the boxed regions of the Rad (1),
and ML, GCL and HI (2) are magnified in panel C-1 and C-2, respectively. Scale bar, 500 mm (A–E) and 100 mm (C-1, C-2). (F) The bar chart illustrates the
distribution of grafted cells versus rostrocaudal distances to injection site at 4 and 8 weeks after transplantation. The number of grafted cells/distance
of serial sections was expressed as a percentage of the total number of surviving cells. Values are represented as mean 6 SEM.
doi:10.1371/journal.pone.0104092.g004
Figure 5. Differentiation of human NSPCs following transplantation into the hippocampus of kindled rats. (A–F) BrdU+ grafted cells
(green) were co-stained with TUJ1 (red, arrowheads in B, C, E, F) in the CA3 region of the hippocampus (A–C) and fimbria (D–F) in rats. (G–J) hNP+
grafted cells (red, arrowheads in G, I, J) were co-localized with TUJ1 (green, arrowheads in H–J) in the hilus of the hippocampus. (J) Orthogonal view
from confocal z-series showed that hNP (red) in nuclei and TUJ1 (green) in cytoplasm were expressed in the same cell. (K, M) Under the dual-filter
microscope, BrdU+ grafted cells co-expressed APC-CC1 in the fimbria (arrows in K), and hNuc+ grafted cells co-expressed GFAP in the CA3 region (an
arrow in M). Scale bar; 200 mm (A), 20 mm (D), 10 mm (G, J), 20 mm (K).
doi:10.1371/journal.pone.0104092.g005
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Figure 6. Differentiation of human NSPCs into GABAergic neurons in the hippocampus of kindled rats. (A–J) BrdU+ grafted cells (green,
A, C, D, F, G, I, J), were co-labeled with GABA (red, B, C, E, F, H–J), in the molecular and granular layer of the dentate gyrus, hilus of the hippocampus
(A–C), and the radiatum layer of the CA3 region (D–J) of rats. (G–I) A large fraction of BrdU+ grafted cells co-expressed GABA, as viewed under the
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was usually stage 4 or 5. The mean seizure stage of SRMS was not
different between both transplanted and vehicle groups (P.0.05;
Fig. 8B). There were significant decreases in the average total time
spent in SRMS at 2 and 3 months after grafting in the
transplanted group (28.068.0 and 47.6624.0 s, respectively) as
compared to the corresponding time points in the vehicle group
(69.0616.9 and 213.5651.5 s, respectively) (P= 0.033 and
P= 0.007, respectively; Fig. 8C). The mean duration of individual
SRMSs was not different in the transplanted group than in the
vehicle group at any time point (P.0.05). The data suggest that
huNSPCs grafting resulted in long-term significant attenuation of
SRMS in a representative TLE model.
Effect of human NSPC transplantation on learning and
memory function
Epilepsy in patients is often accompanied by cognitive decline
[46]. Thus, we examined whether huNSPC transplantation could
affect performance in a Morris water maze test, which assesses
hippocampal-dependent learning and memory function. To
estimate the effect of NSPC transplantation on learning and
memory function in the pilocarpine model, we performed water
maze testing at 3 months post-grafting. Age-matched intact
controls (n= 6) showed the marked decreases in the escape
latencies over the sessions, indicating normal spatial learning
ability. However, epileptic rats in the vehicle group (n= 11) did not
improve significantly in locating the submerged platform over the
trials (Fig. 9A), consistent with other reports, demonstrating
impaired spatial learning [47,48]. During the probe test to
evaluate the memory function, epileptic rats in the vehicle group
spent significantly shorter times in the target quadrant and in the
platform area (Fig. 9B, C), took longer to reach the platform area
(Fig. 9D), and barely crossed the platform area compared with
intact controls (Fig. 9E). In the transplantation group (n= 12), rats
did not show amelioration in overall spatial learning or memory
function, and were not considerably different from the vehicle-
injected group.
We performed water maze testing at 9 weeks post-grafting in
fully kindled rats. Kindled rats of the vehicle-injected and NSPC-
transplanted groups (n= 11 and 8, respectively) showed gradual
decline in escape latency across training days. The probe test was
performed at 24 h after the last training day to evaluate memory
function. NSPC-grafted group were indistinguishable in all
parameters of reference memory (latency to reach the platform
area, platform area crossings, dwell time in the target quadrant,
and dwell time in the platform area) compared to vehicle-injected
group. No significant difference was observed in the learning and
memory function between both groups (data not shown). Thus,
huNSPCs transplantation did not interfere with the ability of
spatial learning and memory retention in kindled rats.
Effect of human NSPC grafting on the expression of
GDNF in host hippocampal astrocytes
Increased GDNF levels in hippocampal astrocytes of the
epileptic brain are known to suppress seizures [49,50]. In this
study, few huNSPC-derived cells after grafting differentiated into
GDNF-expressing astrocytes in the hippocampus in either TLE
model. However, NSPC transplantation induced GDNF expres-
sion in a large part (.80%, n= 6) of host hippocampal astrocytes
in the pilocarpine-treated TLE model, whereas the level of GDNF
expression of host astrocytes was ,72% (n= 4) in age-matched
intact controls and ,46% (n= 6) in vehicle-injected epileptic rats
(Fig. 10). This suggested that the level of GDNF expression was
restored to closer to that of the intact controls after NSPCs
grafting. Thus, the induction of GDNF expression in host
hippocampal astrocytes by huNSPCs transplantation may be
involved in suppressing seizures.
Effect of human NSPC transplantation on aberrant mossy
fiber sprouting
Aberrant sprouting of mossy fibers into the inner molecular
layer of the DG of the hippocampus is one of the best-known
structural changes in TLE models [2–5]. Because mossy fiber
sprouting (MFS) is known to be linked to increased seizure
susceptibility in TLE [51], we examined whether huNSPCs
grafting could reduce MFS in the pilocarpine model. To visualize
mossy fibers, we performed Timm staining that selectively labeled
zinc-containing mossy fibers and recorded the Timm score to
evaluate the extent of MFS. In age-matched intact rats (n= 4),
Timm staining was nearly absent in the supragranular region of
the DG (Fig. 11A, D). However, compared with intact rats,
prominent Timm granules were present in the supragranular
region in pilocarpine-treated rats, indicating aberrant MFS
(Fig. 11B, C, E, F). The statistical analysis showed that the Timm
score for MFS was not significantly different between vehicle-
injected and NSPC-transplanted rats (n= 4 and 4, respectively;
P= 1.0; Fig. 11G). This finding indicates that the significant
reduction in seizure frequency seen with huNSPCs transplantation
was not the result of a change of aberrant mossy fiber sprouting in
the dentate gyrus.
Discussion
This study presents the first evidence that human fetal
telencephalon-derived NSPC transplantation into the adult
epileptic rat brain exerts a therapeutic effect in suppressing
kindling-induced evoked seizures and spontaneous recurrent
seizures in the pilocarpine-induced TLE model. In the kindling
model, huNSPCs grafting showed a considerable reduction in
ADD, seizure duration, and seizure stage for several weeks
following transplantation. However, the seizure-restraining effect
was not lasting, but slowly disappeared by ,6 weeks after grafting,
although the grafts survived and contained GABA-expressing cells
over a longer video-EEG monitoring period (.8 weeks).
While the kindling model exhibits some of the prominent
features of TLE, the disadvantages of kindling are the deficiency of
spontaneous seizures and physiological and morphological simi-
larities of hippocampal lesions compared with human mesial TLE.
In contrast, the pilocarpine model displays characteristic features
of TLE—spontaneous seizures acquired after a brain insult, loss of
cognitive function, behavioral alterations, and poor responses to
AEDs—which mimic human TLE in adults [2,5,24,52]. Thus, we
then transplanted huNSPCs into the bilateral hippocampus of
pilocarpine-induced epileptic rats after SRMSs emerged.
Epileptic animals showed a marked decrease in seizure
frequency and total time spent in seizure at 2 and 3 months after
cell grafting. Furthermore, grafted cells not only showed extensive
dual-filter microscope. (J) Orthogonal view from confocal z-series visualized co-expression of BrdU (green) and GABA (red) in a grafted cell. (K–N)
Orthogonal images show that hNP or hNuc+ grafted cells (red) co-expressed GABA (green) in different layers of the CA3: the stratum lucidum (K),
stratum pyramidale (L and M), and stratum oriens (N). (O–Q) A BrdU+ grafted cells (green) were also co-labeled with calbindin2 (CALB2, red) in the
stratum oriens around the CA3 area. Scale bar, 200 mm (A), 100 mm (D), 50 mm (G), 10 mm (J), 20 mm (K), 10 mm (O).
doi:10.1371/journal.pone.0104092.g006
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Figure 7. Effect of human NSPC grafting on hippocampal-kindled seizures in rats. The mean values of afterdischarge duration (ADD) in
electroencephalograms (A), behavioral seizure duration (B), and seizure stage (C) between vehicle-injected and NSPC-transplanted groups were
compared before (pre-Tx) and after NSPC grafting (post-Tx). Error bars indicate 6SEM. huNSPC grafting significantly reduced all three seizure
parameters—ADD, behavioral seizure duration, and seizure stage—although this seizure-suppressing effect was not permanent. * Significantly
different from the vehicle-injected group at P,0.05; ** significantly different from the vehicle-injected group at P,0.01.
doi:10.1371/journal.pone.0104092.g007
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migration, robust engraftment, long-term survival, and differenti-
ation into three CNS neural cell types around the injection site,
but also caused the addition of a great number of GABAergic
interneurons into the hippocampus in both kindling and pilocar-
pine-treated TLE models. However, although huNSPCs grafting
into the adult epileptic brain exerted a considerable anticonvulsant
effect, the decline in cognitive function commonly associated with
epilepsy did not improve.
Loss of inhibitory interneurons is seen commonly in the
hippocampus of TLE animal models and patients with epilepsy
[5,53-55]. To examine seizure suppression by specifically increas-
ing the inhibitory tone, fetal hippocampal precursors or cells
genetically engineered to express GABA were transplanted into
animal models [9,29,56,57]. These studies reported modest or
transient antiseizure effects, suggesting that cell-based therapies
that augment inhibitory neural transmission could be therapeutic
in patients with TLE.
Recent works have focused on fetal MGE precursor cells as
donor cell types for treating TLE because MGE is the origin of
most cortical, hippocampal, and striatal GABAergic interneurons
in the developing brain [43,58,59]. Transplanted fetal MGE
precursors showed widespread migration and inhibitory synapse
formation onto host cortical pyramidal neurosns in intact brain
[31,60], and reduced the number of electrographic seizures in
mice with a potassium channel mutation [18]. When freshly
harvested mice fetal MGE precursors were grafted into the
hippocampus of adult mice with pilocarpine-treated TLE, the
incidence of seizures markedly decreased and behavioral deficits
improved [19]. Almost all grafted MGE cells exhibited not only
morphologically mature inhibitory interneurons, and expressed
typical molecules of interneurons, but also differentiated into
electrophysiologically functional inhibitory neurons and integrated
into the local circuitry. These results suggest that fetal MGE
precursor grafts appear to be a strong tool to suppress seizures and
recover behavioral deficits in severe adult epileptic mice. However,
despite these promising findings, obtaining freshly dissociated
human fetal MGE precursors for TLE therapy is impractical.
Thus, abundant generation of comparable and safe MGE
precursors from human ES or iPSCs will be necessary before
therapeutic application. Recently, the technology for producing
MGE-like precursors from human ES or iPSCs is currently being
developed [21,26,61].
Another recent study showed that transplantation of rat fetal
MGE-derived NSCs, which were expanded in culture as neuro-
spheres, into adult rats with chronic TLE suppressed SRMS
efficaciously [17]. In that study, adequate numbers of donor cells
for grafting in epilepsy were obtained by expanding MGE-derived
NSCs in dishes as neurospheres. Transplanted cells differentiated
into significant numbers of GABAergic interneurons and anticon-
vulsant neurotrophic factor GDNF-expressing astrocytes [49],
which produced a sustained antiseizure effect over a prolonged
period of time in a chronic TLE model. However, prior to clinical
application of MGE-derived NSCs, developing additional cell
grafting methods will be necessary for enhancing the production of
graft-derived GABAergic neurons, the level of overall seizure
suppression, and the cognitive performance.
Although mouse fetal MGE precursors and rat MGE-derived
NSCs grafts markedly attenuate seizures in epileptic brains of
adult animals, the production of an equivalent MGE-like human
stem cells, such as those derived from developing or adult brain
tissues, or from ES or iPSCs, will be required before any
application to the clinic.
In this study, we prepared huNSPCs derived from the
telencephalic brain tissue of an aborted fetus at 13 weeks of
gestation and maintained them in serum-free growth medium by
passaging through the dissociation of bulk neurospheres in a Good
Manufacturing Practice facility. Under these culture conditions,
the doubling time of huNSPCs was 4–5 days, and cells proliferated
Figure 8. Effect of human NSPC grafting on spontaneous
recurrent motor seizures (SRMSs) in pilocarpine-treated rats.
The mean seizure frequencies (A), seizure stages (B) and total time
spent in seizures (C) were calculated during 1, 2, and 3 months
following transplantation in vehicle-injected and NSPC-transplanted
groups. * Significantly different from the vehicle-injected group at P,
0.05; error bars indicate 6SEM.
doi:10.1371/journal.pone.0104092.g008
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continuously and generated a great number of progeny for over 1
year. The vast majority of cells (.99%) within the neurospheres
expressed immature neural stem cell or progenitor markers: nestin,
vimentin, GFAP, Pax6, and Sox2 [22]. On cytogenetic analysis,
huNSPCs were diploid and retained a normal karyotype after
long-term passage, and an array-based comparative genomic
hybridization (aCGH) study also showed no genomic alteration
(Fig. S5).
Under differentiation conditions, huNSPCs could differentiate
not only into multiple neural cell lineages but also into interneuron
populations, although some of them have generated neurons of
diverse neurotransmitter phenotypes [22]. In this study, huNSPCs
were not precisely derived from the GE of an aborted fetal brain,
Figure 9. Effect of human NSPC grafting on spatial learning and memory function in the pilocarpine-treated rats. (A) Latency to locate
the hidden platform (escape latency) was recorded. In the age-matched intact controls, escape latency decreased gradually and significantly over the
4 days of testing, indicating excellent spatial learning. In contrast, NSPC- and vehicle-injected epileptic rats showed markedly longer latency to escape
the maze than intact controls (P= 0.024 and P=0.006, respectively). (B–E) During probe testing on day 5, parameters of memory retention were
measured in the three groups: dwell time in the target quadrant (B), dwell time in the platform area (C), latency to the platform (D), and platform area
crossings (E). Vehicle-injected epileptic rats exhibited significant deficits in memory retention in terms of all parameters. NSPC-transplanted epileptic
rats also showed significant memory deficits, except dwell time in the platform area. * Significantly different from age-matched intact controls at P,
0.05; error bars indicate 6SEM.
doi:10.1371/journal.pone.0104092.g009
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but broadly from the dorsal and ventral part of the telencephalon.
However, NSPCs expressed NKX2.1 transcription factor, which is
required for specifying MGE-derived GABAergic interneurons
[26,42], and abundantly NR2F2, which is preferentially expressed
in the CGE [26,44,45]. These data exhibit that NSPCs contain a
substantial fraction of GE-derived stem cells which were recently
Figure 10. Effect of human NSPC grafting on the expression of GDNF in host hippocampal astrocytes. GDNF expression in S100b+
hippocampal astrocyte was observed in an age-matched intact control (A–D), vehicle-injected pilocarpine-treated (E–H), and NSPC-transplanted
pilocarpine-treated rats (I–L). Nuclei were counterstained with DAPI (C, G, and K). Arrowheads in A–L indicated S100b/GDNF double-labeled cells.
Arrows in E, G and H denoted S100b+ host hippocampal astrocytes that were devoid of GDNF immunoreactivity in vehicle-injected epileptic rats.
Scale bar, 50 mm. (M) The bar chart represents percentages of S100b+ astrocytes expressing GDNF in the CA3 region of the hippocampus in the three
groups. There was a significant difference between intact controls and vehicle-injected epileptic rats (P= 0.022) and between vehicle-injected and
NSPC-transplanted epileptic rats (P=0.038). * Significantly different from the age-matched intact control group at P,0.05; { significantly different
from vehicle-injected group at P,0.05; error bars indicate 6SEM.
doi:10.1371/journal.pone.0104092.g010
Figure 11. Effect of human NSPC grafting on aberrant mossy fiber sprouting in pilocarpine-treated animals. (A–F) Timm staining
exhibits mossy fiber staining from age-matched intact control (A, D), vehicle-injected pilocarpine-treated (B, E) and huNSPCs-transplanted
pilocarpine-treated rats (C, F) 3 months following transplantation. D–F are high-magnification views of areas indicated by arrows in A–C, respectively.
Arrowheads in D–F indicate the supragranular region of the dentate gyrus. Pilocarpine-treated rats reveal mossy fiber sprouting with an increased
density of Timm granules in the supragranular region (B, C, E, F), whereas control rats did not (A, D). Scale bar, 500 mm (C), 100 mm (F). (G) NSPC-
transplanted and vehicle injected rats had higher Timm scores than the control group (*P,0.05). Error bars, SEM. No significant difference regarding
Timm score was found between NSPC- and vehicle-injected groups.
doi:10.1371/journal.pone.0104092.g011
Human Neural Stem/Progenitor Cell Grafts for Temporal Lobe Epilepsy
PLOS ONE | www.plosone.org 16 August 2014 | Volume 9 | Issue 8 | e104092
reported to be the primary sources of cortical interneurons in
human [62]. Additionally, NSPCs expressed the vental telence-
phalic GABAergic neuronal lineage markers (ASCL1 and DLX2),
GABAergic neuronal markers (GAD1, SLC32A1, and SLC6A1),
and interneuron subtype markers (NPY, SST, and CALB2).
Moreover, ,26% of NSPC-derived differentiated cells expressed
GABA, ,11% of the cells expressed GABA-synthesizing enzyme
GAD2, and the cells released GABA into the culture medium in
response to depolarization due to high potassium.
Thus, huNSPCs, derived from a single donated fetal brain,
could be expanded in culture for extended periods and cryopre-
served into cell banks, from which adequate amounts of cells could
be prepared for transplantation into patients with epilepsy.
Additionally, huNSPCs could give rise to a considerable fraction
of GABAergic interneurons after grafting into the hippocampus of
patients with TLE.
In this study, significant repression of SRMSs by huNSPCs
grafts appeared to be caused by the addition of GABAergic
neurons albeit still immature. Regarding GABAergic neurons,
huNSPCs transplantation additionally provided ,28,000 GA-
BAergic neurons into the hippocampus in the kindling model and
,24,000 GABAergic neurons into each hippocampus in the
pilocarpine-treated model. This addition is substantial, considering
that GABAergic function decreases in TLE [5,53–55,63–65] and
grafted cells release GABA, which facilitates the antiseizure effect.
Although huNSPCs grafting resulted in significant reductions in
all seizure parameters in the kindling model, the significant
seizure-suppressing effect was not permanent, but disappeared
slowly by the seventh week following transplantation. Previous
studies also reported that simply GABA-secreting cell grafts
induced transient antiseizure effects [9,29,56,57]. This transient
antiseizure effect of cell grafting has been observed previously in
most rodent studies [9,66]. This may be not only a consequence of
decreased implanted cell viability or poor integration into epileptic
hippocampal circuits, but also of a decline in GABA release from
grafted cells, desensitization of the GABA receptors [9], or
relatively low number of grafted cells-derived mature GABAergic
interneurons.
In the pilocarpine-treated model, huNSPCs grafting showed a
progressive reduction in seizure frequency and total time spent in
seizure over the post-grafting survival period, and many donor-
derived GABAergic neurons could be found at 3 months following
transplantation. However, most grafted cells appeared not to show
the morphological features of mature interneurons resembling host
inhibitiory hippocampal interneurons. Thus, precise electrophys-
iological, morphological, and molecular studies are needed to
observe some possibilities of functional synaptic integration of
grafted GABAergic neurons on the host hippocampal circuitry.
A prior study has reported that rat fetal MGE-derived NSCs
grafting into rats with chronic epilepsy restrained spontaneous
seizures by the supply of new donor-derdived GDNF-positive cells
with recovery of GDNF expression in host hippocampal astrocytes
[17]. In this study, few huNSPC-derived cells after grafting
differentiated into GDNF-expressing astrocytes in either TLE
model. However, NSPC transplantation induced GDNF expres-
sion in host hippocampal astrocytes in the pilocarpine-treated
TLE model. huNSPCs express FGF-2 at a high level and FGF-2 is
known to induce GDNF expression in astrocytes [67,68].
Increased GDNF levels in hippocampal astrocytes of the epileptic
brain are known to suppress seizures [49,50]. Thus, the induction
of GDNF expression in host hippocampal astrocytes by huNSPCs
transplantation may be involved in suppressing seizures.
huNSPCs grafting could not reverse spatial learning and memory
function in the pilocarpine-treated TLE model. As described above,
when a large part of transplanted fetal MGE precursor cells
differentiated into mature inhibitory interneurons and integrated
functionally into the existing hippocampal neuronal network in the
TLE model, a marked reduction in seizures and some restoration of
behavioral deficits, including spatial learning and memory function,
could be observed [19]. Thus, to not only induce remarkable long-
term seizure suppression but also rescue accompanying cognitive
deficits in epileptic animals, new additional strategies of huNSPCs
grafting should be developed to improve survival and neuronal
differentiation of grafted cells, and the yield of graft-derived mature
GABAergic interneurons, which functionally integrate into the
epileptic hippocampal circuitry. Additionally, restoration of cogni-
tive function may require grafting of NSPCs that are capable of
secreting various therapeutic molecules, such as growth factors,
antiepileptic peptides, neurogenesis-enhancing factors, and anti-
inflammatory/immunomodulatory factors.
Taken together, our results provide the first evidence that human
fetal brain-derived NSPC transplantation into the hippocampus has
therapeutic potentials for managing TLE, particularly with regard
to seizure suppression. huNSPCs, derived from a single donated
fetal brain, could be expanded in culture for a long time, from which
sufficient numbers of cells could be prepared for transplantation into
patients with epilepsy. Transplanted human cells showed extensive
migration, robust engraftment, long-term survival, differentiation
into three CNS neural cell types, and a large number of GABAergic
interneurons around the grafted sites. However, before any clinical
application, further studies to both increase the yield of NSPC
grafts-derived functionally integrated GABAergic neurons and
improve cognitive deficits are still needed.
Supporting Information
Figure S1 Engraftment and distribution of human
NSPCs following transplantation into the hippocampus
of age-matched non-kindled rats. (A) A schematic figure
illustrates the distribution of grafted cells in intact non-kindled rats
8 weeks after transplantation into the CA3 region of the right
hippocampus. Grafted cells were mostly placed around the
injection site (arrow), and seldom observed in the dentate gyrus
(DG) and hilus (HI) of the hippocampus. (B) SC121+ grafted
cells—visualized using fluorescein—were shown around the
injection site. Scale bar, 100 mm.
(TIF)
Figure S2 Engraftment and distribution of human
NSPCs following transplantation into the hippocampus
of pilocarpine-treated rats. hNuc+ cells—visualized using
Texas Red—were located in in the radiatum layer of the CA1 and
CA3 regions, lacunosum molecular layer of the CA1 region,
molecular and granular layer of the dentate gyrus, and hilus of the
hippocampus when brains were analyzed 3 months post-grafts.
Dotted line denotes the boundary between hilus (h) and granular
layer of the dentate gyrus (DG). Scale bar, 200 mm.
(TIF)
Figure S3 Expression of GDNF from transplanted
human NSPCs-derived astrocytes in the hippocampus
of kindled rats. (A–D) Anti-human specific GFAP SC123+
grafted cells, visualized with Texas Red (A) were co-localized with
GDNF, identified using fluorescein (B). Nuclei were counter-
stained with DAPI (C). (E) Orthogonal view from confocal z-series
showed that SC123 and GDNF were co-expressed in cytoplasm of
the same cell. Scale bar; 20 mm (A, E). GDNF, glial-derived
neurotrophic factor.
(TIF)
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Figure S4 Differentiation of human NSPCs following
transplantation into the hippocampus of pilocarpine-
treated rats. (A–D) A large number of hNuc+ grafted cells
expressed undifferentiated cell marker, nestin in the hippocampus
of pilocarpine-treated rats. (E–H) About 10% of hNuc+ grafted
cells differentiated into TUJ1+ neurons (arrowheads in F, G). (I–L)
,60% of hNuc+ grafted cells expressed GFAP. (M–P) A few anti-
human specific cytoplasm SC121+ grafted cells were co-localized
with Olig2, oligodendrocyte progenitor marker (arrows in M–O).
(Q–T) ,21% of hNuc+ grafted cells were co-labeled with GABA.
(D, H, L, P, T) Orthogonal view from confocal z-series visualized
co-expression of grafted cells (red) and various cell markers (green)
in the same cell. Scale bar; 50 mm (A), 20 mm (D).
(TIF)
Figure S5 Cytogenetic analysis of human NSPCs. (A)
Karyotyping and G-banding analysis of huNSPCs revealed a
normal diploid karyotype at passage number 27 (46, XY). (B)
Array CGH analysis of huNSPCs further confirmed their normal
karyotype.
(TIF)
Table S1 Primers used for quantitative real-time PCR.
(DOCX)
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